Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 2 hours ago

‘People in the U.S. need to wake up’: As a mortgage loan officer, I rejected wealthy couples due to overspending. We’re all heading for trouble.

“We’d better get real quick or we’re going to have a financial crisis that makes the Great Recession of 2008 look like a picnic.”

MarketWatch

marketsabout 2 hours ago

Musk hints TSMC may join his mega chip venture, and Intel’s stock is taking a hit

Intel shares are taking a hit on Monday after a report that TSMC may help with Elon Musk’s Terafab factory.

MarketWatch

marketsabout 2 hours ago

An AI ‘reality check’ may take the S&P 500 to 5,000. Here are the trades to make, this strategist says.

Keep an eye on artificial-intelligence spending in the upcoming earnings season, Panmure Liberum’s Joachim Klement said.

MarketWatch